Chemotherapy of meningiomas. Realities and prospects
Keywords:
meningioma, chemotherapy, growth factorsAbstract
Meningioma is one of the popular benign brain tumors. The authors present the evidence that meningiomas respond to chemotherapy in patients with recurrent and unresectable meningiomas. Inhibition of neovascularization is one potential strategy for treating these hypervascular tumors. High levels of growth factors and their receptors have been demonstrated in human tumors. Meningiomas are characterized by overexpression of epidermal growth factor, vascular endothelial growth factor, platelet derived growth factor.
References
Зозуля Ю.А., Верхоглядова Т.П., Шамаев М.И., Малышева Т.А. Гистобиологические принципы классификации опухолей нервной системы и ее клиническое значение // Укр.нейрохірург. журн. — 2001. — №1. — С.32–38.
Ищенко Р.В. Методика капельно-плазменного культивирования опухолевой ткани для экспресс-определения индивидуальной чувствительности к химиопрепаратам // Онкология. — 2002. — Т.4, №1. — С.15–17.
Козлов А.В. Нехирургические методы в комплексе лечения менингиом //Вопр.нейрохирургии. — 2001. — №2. — С.29–33.
Копнин Б.П. Мишени действия онкогенов и опухолевых супрессоров: ключ к пониманию базовых механизмов канцерогенеза // Биохимия. — 2000. — Т.65. — С.5–33.
Adegbite A.B., Khan M.I., Paine K.W.E., Tan L.K.The recurrence of intracranial meningiomas after surgical treatment // J. Neurosurg. — 1983. — V.58. — P.51–56.
Akeyson E.W., McCutcheon I.E. Management of benign and aggressive intracranial meningiomas // Oncology. — 1996. — V.10, N5. — P.747–759.
Baldari S., Restifo P.G., Cosentino S., Minutoli F. Investigation of brain tumours with (99m)Tc-MIBI SPET // Q. J. Nucl. Med. — 2002. — V.46, N4. — P.336–345.
Bello L., Zhang J., Nikas D.C. et al. a(v)b3 and a(v)b5 integrin expression in meningiomas // Neurosurgery. — 2000. — V.47. — P.1185–1195.
Bernstein M., Villamil A., Davidson G. et al. Necrosis in a meningioma following systemic chemotherapy: Case report // J. Neurosurg. — 1994. — V.81. — P.284–287.
Camby I., Nagy N., Rombaut K. et al. Influence of epidermal growth factor and gastrin on the cell proliferation of human meningiomas versus astrocytic tumors maintained as ex vivo tissue cultures // Neuropeptides. — 1997. — V.31. — P. 217–225.
Carroll R.S., Black P.M., Zhang J. et al. Expression and activation of epidermal growth factor receptors in meningiomas // J. Neurosurg. — 1997. — V.87. — P.315–323.
Crombet T., Torres O., Rodriguez V. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study // Hybridoma. — 2001. — V.20, N2. — P.131–136.
Das A., Tan W.L., Smith D.R. Expression of the inhibitor of apoptosis protein survivin in benign meningiomas // Cancer Lett. — 2003. — V.193, N2. — P.217–223.
Davis C. Surgical and non-surgical treatment of symptomatic intracranial meningiomas // Brit. J. Neurosurg. — 1995. — V.9. — P.295–302.
Detta A., Kenny B.G., Smith C. et al. Correlation of proto-oncogene expression and proliferation in meningiomas // Neurosurgery. — 1993. — V.33. — P.1065–1074.
De Jesus O., Sekhar L.N., Parikh H.K. et al. Long-term follow up of patients with meningiomas involving the cavernosus sinus: recurrence, progression, and quality of life // Neurosurgery. — 1996. — V.39. — P.915–920.
Dmitriev I., Kashentseva K., Rogers B.F. et al. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells // J. Virol. — 2000. — V.74. — P.6875–6884.
Donnini S., Machein M.R., Plate K.H., Weich H.A. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas // J. Pathol. — 1999. — V.189. — P.66–71.
Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer // Nature. — 2001. — V.411. — P.342–348.
Giordano F., Savarino A., Pagni C.A. Spinal meningioma during hydroxyurea therapy. A paradoxycal case report // Neurol. Sci. — 2002. — V.23, N3. — P.127–129.
Groves M.D., DeMonte F., Yung W.A.K. Chemotherapeutic treatment of aggressive meningeal tumors (abstract) // Skull Base Surg. — 1995.—V.5, suppl.1.—P.2.
Hellwig D., Samnick S., Reif J. et al. Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma // Clin. Nucl. Med. — 2002. — V.27, N11. — P.781–784.
Hengartner M.O. The biochemistry of apoptosis // Nature. — 2000. — V.407. — P.770–776.
Herken R., Merker H.J., Krowke R. Investigation of the effect of hydroxyurea on the cell cycle and the development of necrosis in the embryonic CNS of mice // Teratology. — 1978. — V.18. — P.103–118.
Jддskelдinen J. Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients // Surg. Neurol. — 1986. — V.25. — P.461–469.
Johnson M.D., Woodard A., Okediji E.J. et al. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase // J. Neurooncol. — 2002. — V.56, N2. — P.133–142.
Kaba S.E., DeMonte F., Bruner J.M. et al. The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B // Neurosurgery. — 1997. — V.40. — P.271–275.
Kyritsis A.P. Chemotherapy for meningiomas // J. Neurooncol. — 1996. — V.29, N3. — P.269–272.
Lopes M.B.S. Angiogenesis in brain tumors // Microsc. Res. Tech. — 2003. — V.60. — P.225–230.
Maнllo A., Dнaz P., Blanco A. Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors // Cytometry. — 1999. — V.38 — P.118–123.
Mason W.P., Gentili F., Macdonald D.R. et al. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma // J. Neurosurg. — 2002. — V.97. — P341–346.
McCutcheon I.E., Flyvbjerg A., Hill H. et al. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice // J. Neurosurg. — 2001. — V.94. — P.487–492.
Mirimanoff R.O., Dosoretz D.E., Linggood R.M. et al. Meningioma: analysis of recurrence and progression following neurosurgical resection // J. Neurosurg. — 1985. — Vol.62. — P.18 — 24.
Newman S.A. Meningiomas: A quest for the optimum therapy // J. Neurosurg. — 1994. — V.80. — P.191–194.
Newton H.B., Slivka M.A., Stevens C. Hydroxyurea chemotherapy for unresectable or residual meningioma // J. Neurooncol. — 2000. — V.49, N2. — P.165–170.
Park Y.S., Lee J.H., Bondar J. et al. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells // Planta Med. — 2002. — V.68, N5. — P.397–401.
Pistolesi S., Fontanini G., Boldrini L. et al. The role of somatostatin in vasogenic meningioma associated brain edema // Tumori. — 2003. — V.89, N2. — P.136–140.
Rosenthal M. A., Ashley D. L., Cher L. Treatment of high risk or recurrent meningiomas with hydroxyurea // J. Clin. Neurosci. — 2002. — V.9, N2. — P.156–158.
Saaristo A., Karpanen T., Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis // Oncogene. — 2000. — V.19. — P.6122–6129.
Salhia B., Rutka J.T., Lingwood C. et al. The treatment of malignant meningioma with verotoxin // Neoplasia. — 2002. — V.4, N4. — P.304–311.
Sharif S., Brennan P., Rawluk D. Non-surgical treatment of meningioma: a case report and review // Brit. J. Neurosurg. — 1998. — V.12. — P.369–372.
Schmitt C.A., Lowe S.W. Apoptosis and therapy // J. Pathol. — 1999. — V.187. — P.127–137.
Schrell U.M., Gauer S., Kiesewetter F. et al. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop // J. Neurosurg. — 1995. — V.82. — P.600–607.
Schrell U.M., Rittig M.G., Anders M. et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway // J. Neurosurg. — 1997. — V.86, N5. — P.845–852.
Schrell U.M., Rittig M.G., Anders M. et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea // J. Neurosurg. — 1997. — V.86, N5. — P.840–844.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment // J. Neurol. Neurosurg. Psychiatry. — 1957. — V.20. — P.22–39.
Skaletz-Rorowski A., Muller J.G., Kroke A. et al. Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition // Europ. J. Cell. Biol. — 2001. — V.80, N3. — P.207–212.
Stafford S.L., Perry A., Suman V.J. et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo clinic patients, 1978 through 1988 // Mayo Clin. Proc. — 1998. — V.73. — P.936–942.
Stambolic V., Mak T.W., Woodgett J.R. Modulation of cellular apoptotic potential: contributions to oncogenesis // Oncogene. — 1999. — V.18. — P.6094–6103.
Stewart D.J., Dahrouge S., Wee M. et al. Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas // J. Neurol. Oncol. — 1995. — V.24. — P.189–194.
Taut F.J., Zeller W.J. In vitro chemotherapy of steroid receptor positive human meningioma low-passage primary cultures with nitrosourea-methionine-steroid conjugates // Clin. Neuropharmacol. — 1996. — V.19, N6. — P.520–525.
Todo T., Adams E.F., Fahlbusch R. Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation // J. Neurosurg. — 1993. — V.78. — P.463–469.
Tsuchida T., Matsudaira T., Yoshimura K. et al. Chemosensitivity of cultured meningiomas // Hum. Cell. — 1995. — V.8, N4. — P.155–156.
Yamasaki F., Yoshioka H., Hama S. et al. Recurrence of meningiomas
Influence of vascular endothelial growth factor expression // Cancer. — 2000. — V.89. — P.1102–1110.
Yazaki T., Takamiya Y., Costello P. C. et al. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470 // J. Neurooncol. — 1995. — V.23, N1. — P.23–29.
Yoshioka H., Hama S., Taniguchi E. et al. Peritumoral brain edema associated with meningioma influence of vascular endothelial growth factor expression and vascular blood supply // Cancer. — 1999. — V.85. — P.936–944.
Zhang Z. J., Muhr C., Wang J. L. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells // Anticancer Res. — 1996. — V.16, N2. — P.717–723.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2004 A. Ya. Glavatsky, V. V. Kondratyuk, S. S. Makeev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
